Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia
· Delayed Price · Currency is MYR 1.310
+0.010 (0.77%)
At close: May 23, 2025
Duopharma Biotech Berhad Revenue
Duopharma Biotech Berhad had revenue of 262.74M MYR in the quarter ending March 31, 2025, with 36.16% growth. This brings the company's revenue in the last twelve months to 883.47M, up 26.71% year-over-year. In the year 2024, Duopharma Biotech Berhad had annual revenue of 813.70M with 15.46% growth.
Revenue (ttm)
883.47M
Revenue Growth
+26.71%
P/S Ratio
1.43
Revenue / Employee
451.44K
Employees
1,957
Market Cap
1.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 813.70M | 108.97M | 15.46% |
| Dec 31, 2023 | 704.73M | 8.01M | 1.15% |
| Dec 31, 2022 | 696.72M | 57.54M | 9.00% |
| Dec 31, 2021 | 639.18M | 69.27M | 12.16% |
| Dec 31, 2020 | 569.90M | -6.56M | -1.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Malayan Banking Berhad | 27.91B |
| Public Bank Berhad | 14.04B |
| Tenaga Nasional Berhad | 65.83B |
| CIMB Group Holdings Berhad | 20.87B |
| IHH Healthcare Berhad | 24.38B |
| Celcomdigi Berhad | 12.75B |
| Press Metal Aluminium Holdings Berhad | 14.91B |
| Hong Leong Bank Berhad | 6.19B |